SORAFENIB COMBINED WITH NON-CONVENTIONAL CHEMOTHERAPY PRODUCES DEEP REMISSIONS IN FMS-LIKE TYROSINE KINASE-3 GENE/INTERNAL TANDEM DUPLICATION POSITIVE (FLT-3/ITD+) POSITIVE ACUTE MYELOID LEUKEMIA (AML) PATIENTS

被引：0
|
作者：
Thacker, Nirav [1 ]
Banavali, Shripad [1 ]
Arora, Brijesh [1 ]
Narula, Gaurav [1 ]
Prasad, Maya [1 ]
Patkar, Nikhil [1 ]
Tembhare, Prashant [1 ]
Subramanian, P. G. [1 ]
机构：
[1] Tata Mem Hosp, Bombay 400012, Maharashtra, India
来源：
PEDIATRIC BLOOD & CANCER | 2016年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
560
引用
收藏
页码：S29 / S29
页数：1
相关论文
共 50 条
  • [1] Sorafenib Combined with Non-Conventional Chemotherapy Produces Deep Remissions in FMS-like Tyrosine Kinase-3 Gene / Internal Tandem Duplication Positive (FLT-3 / ITD+) Acute Myeloid Leukemia (AML) Patients
    Banavali, Shripad
    Thacker, Nirav
    Arora, Brijesh
    Narula, Gaurav
    Prasad, Maya
    Pradhan, Nirmalya
    Panda, Saroj
    Patkar, Nikhil
    Tembhare, Prashant
    Subramanian, Papagudi Ganesan
    BLOOD, 2015, 126 (23)
  • [2] Activating internal tandem duplication mutations of the fms-like tyrosine kinase-3 (FLT3-ITD) at complete response and relapse in patients with acute myeloid leukemia
    Nazha, Aziz
    Cortes, Jorge
    Faderl, Stefan
    Pierce, Sherry
    Daver, Naval
    Kadia, Tapan
    Borthakur, Gautam
    Luthra, Raja
    Kantarjian, Hagop
    Ravandi, Farhad
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (08): : 1242 - 1245
  • [3] Prevalence of FMS-like tyrosine kinase 3/internal tandem duplication (FLT3/ITD+) in de novo acute myeloid leukemia patients categorized according to cytogenetic risk
    Krum, Everson Augusto
    Yamamoto, Mihoko
    Lopes Ferrari Chauffaille, Maria de Lourdes
    SAO PAULO MEDICAL JOURNAL, 2009, 127 (01): : 23 - 27
  • [4] Sorafenib in Relapsed AML With FMS-Like Receptor Tyrosine Kinase-3 Internal Tandem Duplication Mutation
    Giri, Smith
    Hamdeh, Shadi
    Bhatt, Vijaya Raj
    Schwarz, James K.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (05): : 508 - 514
  • [5] Azacitidine as post-remission consolidation for sorafenib-induced remission of Fms-like tyrosine kinase-3 internal tandem duplication positive acute myeloid leukemia
    Gill, Harinder
    Man, Cheuk-Him
    Ip, Alvin H. W.
    Choi, William W. L.
    Chow, Howard C. H.
    Kwong, Yok-Lam
    Leung, Anskar Y. H.
    HAEMATOLOGICA, 2015, 100 (07) : E250 - E253
  • [6] QuANTUM-First: Efficacy by Age in Newly Diagnosed (nd) Patients With FMS-Like Tyrosine Kinase 3-Internal Tandem Duplication-Positive (FLT3-ITD+) Acute Myeloid Leukemia (AML)
    Erba, Harry P.
    Patkowska, Elzbieta
    Cortes, Jorge
    Perl, Alexander E.
    Sekeres, Mikkael A.
    Dombret, Herve
    Amadori, Sergio
    Wang, Jianxiang
    Levis, Mark J.
    Schlenk, Richard F.
    Liu, Li
    Kamel, Yasser Mostafa
    Imadalou, Karima
    Laadem, Abderrahmane
    Lesegretain, Arnaud
    Montesinos, Pau
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S299 - S299
  • [7] Fms-like tyrosine kinase 3 positive acute myeloid leukemia
    Isidori, Alessandro
    Visani, Giuseppe
    Ferrara, Felicetto
    CURRENT OPINION IN ONCOLOGY, 2023, 35 (06) : 589 - 593
  • [8] Upfront Addition of Sorafenib and Cladribine Based Chemotherapy in FMS-Like-Tyrosine Kinase-3 Internal Tandem Duplication (FLT3-ITD) Mutated Pediatric-Acute Myeloid Leukemia (AML): A Single Centre Experience
    Pradhan, N. D.
    Vijaysekharan, K.
    Tandon, S.
    Sankaran, H.
    Prasad, M.
    Narula, G.
    Patkar, N.
    Tembhare, P.
    Subramanian, P. G.
    Banavali, S.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S187 - S187
  • [9] Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation
    Sora, Federica
    Chiusolo, Patrizia
    Metafuni, Elisabetta
    Bellesi, Silvia
    Giammarco, Sabrina
    Laurenti, Luca
    Ausoni, Giuseppe
    Zini, Gina
    Bayer, Alina J.
    Mario, Balducci
    Leone, Giuseppe
    Sica, Simona
    LEUKEMIA RESEARCH, 2011, 35 (03) : 422 - 423
  • [10] Quantum-First: Safety By Treatment Phase and By Age in Newly Diagnosed (nd) Patients (pts) with FMS-like Tyrosine Kinase 3-Internal Tandem Duplication ( FLT3-ITD) Positive Acute Myeloid Leukemia (AML)
    Erba, Harry P.
    Dombret, Herve
    Perl, Alexander
    Mitov, Tsvetomir
    Liu, Li
    Kamel, Yasser Mostafa
    Imadalou, Karima
    Choi, Youngsook
    Levis, Mark J.
    Schlenk, Richard F.
    BLOOD, 2023, 142
12345